![CannaTech's Podcast artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts113/v4/65/b4/87/65b487f2-edeb-059a-a1e9-fc8cadeaf81e/mza_10467681838506300315.jpg/100x100bb.jpg)
Saul interviews David Bassa on the recent sale of Stero BioTechs to Kalytera
CannaTech's Podcast
English - April 03, 2020 16:00 - 9 minutes - 6.58 MBHealth & Fitness cannabis medical cannabis israel cannabis cannatech Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Mr. David Bassa is an experienced and proficient entrepreneur.
David owns a number of pharmaceuticals and drug development companies, led the first Cannabis pharma ‘Exit’ in Israel, founder & Previously CEO of Talent Biotech (SOLD),and other ventures.
Shareholder in more than 20 startups in biotech and high tech, main shareholder & CEO of Stero Biotechs, CannaLean Biotechs, CannaMore Biotechs and more startups in the pharmaceutical and Cannabis fields.